| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |